Pulmonary and Respiratory Medicine
999 articles · 28 journals
Journals in this subcategory (28)
- JTCVS Techniques · Elsevier (90)
- Respiratory Medicine Case Reports · Elsevier (86)
- CHEST · Elsevier (80)
- Respiratory Medicine and Research · Elsevier (80)
- The Journal of Thoracic and Cardiovascular Surgery · Elsevier (80)
- Heart & Lung · Elsevier (75)
- Archivos de Bronconeumología · Elsevier (65)
- The Lancet Respiratory Medicine · Elsevier (53)
- JTO Clinical and Research Reports · Elsevier (50)
- Pulmonary Circulation · Wiley (46)
- Respirology · Wiley (40)
- Pediatric Pulmonology · Wiley (39)
- JTCVS Structural and Endovascular · Elsevier (38)
- Clinics in Chest Medicine · Elsevier (35)
- Respiratory Investigation · Elsevier (32)
- Respiratory Physiology & Neurobiology · Elsevier (25)
- Respirology Case Reports · Wiley (23)
- Open Respiratory Archives · Elsevier (18)
- Chinese Medical Journal Pulmonary and Critical Care Medicine · Elsevier (15)
- Thoracic Cancer · Wiley (11)
- Clinical and Translational Allergy · Wiley (9)
- npj Primary Care Respiratory Medicine · Springer Nature (9)
- BMC Pulmonary Medicine · Springer Nature (0)
- Current Allergy and Asthma Reports · Springer Nature (0)
- European Journal of Cardio-Thoracic Surgery · Springer Nature (0)
- General Thoracic and Cardiovascular Surgery · Springer Nature (0)
- Lung · Springer Nature (0)
- Respiratory Research · Springer Nature (0)
- Mucus Plugs in COPD: From Soft Endpoints to the Hard Evidence Based on Imaging
- Global hospital admission and case fatality risks among patients with influenza virus infection: a systematic review and meta-analysis
- Lung cancer: sharing progress in an equitable way
- NEWS2 and the timing of antibiotics in suspected sepsis
- From the cost of asthma to the economic dividends of asthma control
- Survival is not the end(point): the second phase of ECPR care
- Identifying the residual unmet need in severe asthma
- Unravelling of tuberculosis control in Ukraine
- NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study
- Global economic burden attributable to asthma, 2025–50: a global modelling analysis of 154 countries and territories
- Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies
- Cryobiopsy versus conventional bronchoscopic sampling for peripheral pulmonary lesions (Cryo-RCT): an open-label, parallel-group, randomised trial
- Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges
- Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies
- Amivantamab, lazertinib, and bevacizumab: a chemotherapy-free option for patients with advanced EGFR-mutant NSCLC with acquired resistance to a third-generation EGFR TKI
- Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial
- South Africa shifts away from salbutamol-only asthma relief
- When a vulnerable lung meets a changing climate
- Interstitial lung diseases in a changing climate: emerging risks and opportunities to improve care
- Efzofitimod versus placebo in patients with pulmonary sarcoidosis (EFZO-FIT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- Corticosteroid reduction and the endpoint challenge in sarcoidosis: striving for the lowest dose of uncertainty
- Long-term safety and efficacy of twice-yearly depemokimab in type 2 asthma with an eosinophilic phenotype: 2-year integrated analysis of the phase 3a SWIFT-1 and SWIFT-2 studies and AGILE open-label extension
- Twice-yearly depemokimab: beyond dosing convenience
- The present and future of chronic obstructive pulmonary disease prevention, diagnosis, and management in China: a Lancet Respiratory Medicine Commission
- From coverage to equitable reach: addressing social inequalities in COPD in China
- Reshaping COPD care in China: bridging geographical divides and empowering health-care workers
- Preparedness for conflict in medical facilities
- Tuberculosis preventive treatment in high-burden settings: inequality in benefit, evidence, and potential harms
- When spirometry is normal: can FeNO fill the gap in asthma diagnosis?
- In the era of adjuvant alectinib, what can we learn from the E4512 trial of adjuvant crizotinib?